Sisul receives Center of Excellence designation
Center of Excellence Recognizes High Degree of Experience with New Technology
BLACKFOOT, ID – September 17, 2021 – Bingham Healthcare today announced that David M. Sisul, MD, urologist, has been designated as a Center of Excellence for GreenLight™ Laser Therapy treatment—a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms.
GreenLight Laser Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency, and incomplete bladder emptying. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.1 The Center of Excellence designation recognizes Dr. Sisul’s high degree of experience with GreenLight Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from benign prostatic hyperplasia (BPH).1
BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2
“Being designated as a GreenLight Center of Excellence is a meaningful recognition for us, as we strive to provide the best possible treatment of urological conditions for patients in East Idaho,” said David Sisul, MD, urologist at Bingham Healthcare. “For years, the primary options for treating BPH were through behavior modifications, medications, or invasive surgery. However, medications may not work for everyone and may have undesirable side effects such as dizziness, sexual dysfunction, and lower sex drive.3 With GreenLight Laser Therapy, we’re able to provide relief of BPH for men who do not want to take medication or want to avoid invasive surgery.”
GreenLight Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight typically has no overall deleterious impact on sexual function.1 GreenLight Laser Therapy is a long-term solution without the need for BPH medication.1
“After years of waking up multiple times a night to use the bathroom, and not being happy with the results of their medications, patients have found this minimally invasive therapy a life-changing experience,” said Sisul. “The best part is that the procedure doesn’t require hospitalization and people are able to go back to doing the activities they love after just a few days.”*
GreenLight Laser Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 1 million patients around the world have been successfully treated with GreenLight Laser Therapy.4
Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570-8.
2. What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic- hyperplasia-(bph).
3. Roger K, Gilling P. Fast Facts: Benign Prostatic Hyperplasia, 7th edition. Health Press. 2011.
4. Data on file with Boston Scientific.
* Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the use of referenced technologies but may not be appropriate for every patient or case. Decisions surrounding patient care depend on the physician’s professional judgment in consideration of all available information for the individual case.
Boston Scientific (BSC) does not promote or encourage the use of its devices outside their approved labeling. Case studies
Our content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.Return to Articles